Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system

Xiaodan Wu1, Xiantao Wang1

  • 1Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University & Guangxi Key Laboratory of Precision Medicine in Cardio-cerebrovascular Diseases Control and Prevention & Guangxi Clinical Research Center for Cardio-cerebrovascular Diseases, China.

Stem Cell Research
|March 24, 2023
PubMed

Insights

Researchers created a TBX20-knockout human embryonic stem cell line. This new cell line is vital for studying TBX20

Area of Science:

  • Developmental Biology
  • Stem Cell Biology
  • Genetics

Background:

  • The TBX20 gene is essential for embryonic development.
  • TBX20 dysfunction is linked to congenital heart defects, intellectual disability, and cancer.

Purpose of the Study:

  • To establish a TBX20-knockout human embryonic stem cell (hESC) line.
  • To provide a tool for investigating the role of TBX20 in human development and disease.

Main Methods:

  • Generation of a TBX20-knockout hESC line (WAe009-A-84) using gene editing techniques.
  • Characterization of the hESC line for pluripotency, karyotype stability, and differentiation potential.

Main Results:

  • The established TBX20-knockout hESC line retains key stem cell characteristics.
  • The cell line exhibits pluripotency and a normal karyotype.
  • Demonstrated in vivo differentiation capacity into all three germ layers.

Conclusions:

  • The TBX20-knockout hESC line is a robust model for studying TBX20 function.
  • This resource has significant potential for advancing regenerative medicine and disease modeling research.
  • Facilitates understanding of TBX20's role in human embryogenesis and associated pathologies.